keppra

$975M Total Revenue worldwide in 2013
$431M Total Revenue in Europe in 2013
$305M Total Revenue in North America in 2013

Insightful reports built by experienced analysts on keppra. We bring you 4 reports from 2 markets, comparing keppra-related activities versus 3 topics, applying 2 measures.
Europe and World are considered as the most covered markets. keppra is tightly harmonized with following topics: Generic pharmaceuticals, Non Generic pharmaceuticals and Vimpat.

First 6 related reports

explore more